Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

NCT04494295 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT04494295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04494295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Lead sponsor
Integra LifeSciences Corporation
Phase
Observational
Overall status
Recruiting
Start date
October 23, 2020
Completion date
October 15, 2029
Enrollment
500 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

supratentorial hemorrhage